Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioCryst Pharmaceuticals Inc
BCRX
Healthcare
Biotechnology
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of...
hereditary angioedema (HAE) attacks and RAPIVAB (peramivir injection) for the treatment of acute uncomplicated influenza in the United States. Its other products and product candidates include BCX10013, RAPIACTA (peramivir injection), PERAMIFLU (peramivir injection), and early-stage discovery programs. BCX10013, is a potent and specific Factor D inhibitor. RAPIACTA focuses on uncomplicated seasonal influenza. RAPIVAB (peramivir injection) is approved in the United States for the treatment of acute uncomplicated influenza for patients six months and older.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:BCRX)
New Post
View:
Posts & Comments
Threaded Posts
(92)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 06, 2024 3:15pm
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Ou
JUST IN: $BCRX BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance | BenzingaMonday,@BioCryst Pharmaceuticals Inc@(NASDAQ:BCRX) reported a first-quarter
...more
(92)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on May 06, 2024 1:00pm
BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estim
Just In: $BCRX BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates | BenzingaBioCryst Pharmaceuticals (NASDAQ: BCRX) came out with a quarterly loss of $0.17 per share versus the Zacks
...more
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Jan 14, 2022 7:32am
4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!
$BCRX $IPSC $DYAI $CDNA Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches
...more
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Mar 17, 2021 9:55pm
BCRX LONG!
My largest holding Awaiting Factor D news Mar 22. This can be life changing.
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Feb 01, 2021 3:47pm
BOOM!!!!! eom
Now we are getting noticed. Still holding my shares.
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Jan 22, 2021 11:41am
RE:RE:This is a long term hold for me
I have been accumulatig BCRX since the $3's up to and including the $9's more recently. Seems to have worked out for me. So many catalysts and two drugs already
...more
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Jan 06, 2021 11:52pm
RE:This is a long term hold for me
I have been accumulating on the dips. Just a matter of time.
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Dec 08, 2020 8:22am
This is a long term hold for me
I haven't sold a single share and I will hold through 2021 until the catalysts play out. The risk reward scenereo here is just incredible. We have been waiting a long time to
...more
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Dec 03, 2020 11:56pm
FDA APPROVED !!!!!!
Short squeeze may be epic here. Will be intresting day tomorrow and the month ahead.. Be well my friends
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Nov 28, 2020 10:45pm
RE:RE:This is getting interesting
Hope you are reaping the reward my friend. Still holding here and finally some upside.
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Nov 11, 2020 12:04pm
Recent News Release
https://ir.biocryst.com/node/21781/pdf
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Oct 19, 2020 1:05pm
RE:RE:RE:This is getting interesting
i'm using the dips to add more. I hope I guess right here. The risk reward here is interesting. I can't ignore their pipeline. I can't understand why this is
...more
(19)
•••
mevani
X
View Profile
View Bullboard History
Comment by
mevani
on Aug 13, 2020 4:26pm
RE:RE:This is getting interesting
Hopefully we will see more days like today. I am with you my friend.
(6)
•••
nolalu
X
View Profile
View Bullboard History
Comment by
nolalu
on Aug 08, 2020 11:44am
RE:This is getting interesting
Been here a while so would like to see a little reward.
(19)
•••
mevani
X
View Profile
View Bullboard History
Post by
mevani
on Aug 03, 2020 11:31pm
This is getting interesting
Holding for now. I like th risk reward scenerio here. Time will tell.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada